Differential radiological features of patients infected or colonised with slow-growing non-tuberculous mycobacteria.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
10 06 2024
Historique:
received: 19 01 2024
accepted: 04 06 2024
medline: 11 6 2024
pubmed: 11 6 2024
entrez: 10 6 2024
Statut: epublish

Résumé

Non-tuberculous mycobacterial pulmonary disease (NTM-PD) is considered a growing health concern. The majority of NTM-PD cases in Europe are caused by slow-growing mycobacteria (SGM). However, distinct radiological features of different SGM remain largely uninvestigated. We applied a previously described radiological score to a patient cohort consisting of individuals with isolation of different SGM. Correlations between clinical data, species and computed tomography (CT) features were examined by logistic and linear regression analyses, as well as over the course of time. Overall, 135 pulmonary CT scans from 84 patients were included. The isolated NTM-species were mainly Mycobacterium avium complex (MAC, n = 49), as well as 35 patients with non-MAC-species. Patients with isolation of M. intracellulare had more extensive CT findings compared to all other SGM species (coefficient 3.53, 95% Cl - 0.37 to 7.52, p = 0.075) while patients meeting the ATS criteria and not undergoing therapy exhibited an increase in CT scores over time. This study provides insights into differential radiological features of slow-growing NTM. While M. intracellulare exhibited a tendency towards higher overall CT scores, the radiological features were similar across different SGM. The applied CT score might be a useful instrument for monitoring patients and could help to guide antimycobacterial therapy.

Identifiants

pubmed: 38858499
doi: 10.1038/s41598-024-64029-0
pii: 10.1038/s41598-024-64029-0
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

13295

Informations de copyright

© 2024. The Author(s).

Références

Dahl, V. N. et al. Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review. Int. J. Infect. Dis. 125, 120–131 (2022).
doi: 10.1016/j.ijid.2022.10.013 pubmed: 36244600
Hoefsloot, W. et al. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: An NTM-NET collaborative study. Eur. Respir. J. 42(6), 1604–1613 (2013).
doi: 10.1183/09031936.00149212 pubmed: 23598956
Griffith, D. E. et al. An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am. J. Respir. Crit. Care Med. 175(4), 367–416 (2007).
doi: 10.1164/rccm.200604-571ST pubmed: 17277290
Lange, C. et al. Consensus management recommendations for less common non-tuberculous mycobacterial pulmonary diseases. Lancet Infect. Dis. 22(7), e178–e190 (2022).
doi: 10.1016/S1473-3099(21)00586-7 pubmed: 35090639
Wassilew, N., Hoffmann, H., Andrejak, C. & Lange, C. Pulmonary disease caused by non-tuberculous mycobacteria. Respiration. 91(5), 386–402 (2016).
doi: 10.1159/000445906 pubmed: 27207809
Gommans, E. P. A. T. et al. Risk factors for mortality in patients with pulmonary infections with non-tuberculous mycobacteria: A retrospective cohort study. Respir. Med. 109(1), 137–145 (2015).
doi: 10.1016/j.rmed.2014.10.013 pubmed: 25464905
Provoost, J. et al. A retrospective study of factors associated with treatment decision for nontuberculous mycobacterial lung disease in adults without altered systemic immunity. BMC Infect. Dis. 18(1), 659 (2018).
doi: 10.1186/s12879-018-3559-x pubmed: 30547753 pmcid: 6295085
Haworth, C. S. et al. British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD). Thorax. 72(Suppl 2), ii1–ii64 (2017).
doi: 10.1136/thoraxjnl-2017-210927 pubmed: 29054853
Colaneri, M. et al. Is a radiological score needed to define the severity of Nontuberculous mycobacteria lung disease?. New Microbiol. 45(4), 237–242 (2022).
pubmed: 36066215
Cowman, S. A. et al. Latent class analysis to define radiological subgroups in pulmonary nontuberculous mycobacterial disease. BMC Pulm. Med. 18(1), 1–8 (2018).
doi: 10.1186/s12890-018-0675-8
Hwang, J. A., Kim, S., Jo, K. W. & Shim, T. S. Natural history of Mycobacterium avium complex lung disease in untreated patients with stable course. Eur. Respir. J. https://doi.org/10.1183/13993003.00537-2016 (2017).
doi: 10.1183/13993003.00537-2016 pubmed: 28275170
Shu, C. C. et al. Clinical characteristics and prognosis of nontuberculous mycobacterial lung disease with different radiographic patterns. Lung. 189(6), 467–474 (2011).
doi: 10.1007/s00408-011-9321-4 pubmed: 21956280
Song, J. W. et al. High-resolution CT findings of Mycobacterium avium-intracellulare complex pulmonary disease: Correlation with pulmonary function test results. AJR Am. J. Roentgenol. 191(4), 1070 (2008).
doi: 10.2214/AJR.07.3505
Helbich, T. H. et al. Cystic fibrosis: CT assessment of lung involvement in children and adults. Radiology. 213(2), 537–544 (1999).
doi: 10.1148/radiology.213.2.r99nv04537 pubmed: 10551238
Hollings, N. P., Wells, A. U., Wilson, R. & Hansell, D. M. Comparative appearances of non-tuberculous mycobacteria species: A CT study. Eur. Radiol. 12(9), 2211–2217 (2002).
doi: 10.1007/s00330-001-1282-1 pubmed: 12195472
Zoumot, Z. et al. Mycobacterium avium complex infection in non-cystic fibrosis bronchiectasis. Respirology. 19(5), 714–722 (2014).
doi: 10.1111/resp.12287 pubmed: 24690015
Shinfuku, K. et al. The usefulness of change in CT score for evaluating the activity of Mycobacterium abscessus (Mab) pulmonary disease (Mab-PD). PLoS One. 18(2), e0281103 (2023).
doi: 10.1371/journal.pone.0281103 pubmed: 36753471 pmcid: 9907801
Daley, C. L. et al. Treatment of nontuberculous mycobacterial pulmonary disease: An official ATS/ERS/ESCMID/IDSA clinical practice guideline. Eur. Respir. J. https://doi.org/10.1183/13993003.00535-2020 (2020).
doi: 10.1183/13993003.00535-2020 pubmed: 32636299 pmcid: 8375621
R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria. https://www.r-project.org/ (2018).
Wickham, H. et al. Welcome to the Tidyverse. J. Open Source Softw. 4(43), 1686 (2019).
doi: 10.21105/joss.01686
Harrison, E. D. T. P. R. finalfit: Quickly Create Elegant Regression Results Tables and Plots when Modelling. R package version 1.0.7. https://github.com/ewenharrison/finalfit (2023).
Weygaerde, Y. V., Cardinaels, N., Bomans, P., Chin, T., Boelens, J., André, E., et al. Clinical relevance of pulmonary non- tuberculous mycobacterial isolates in three reference centres in Belgium: A multicentre retrospective analysis. 1–10 (2019).
Garcia, B. et al. Chest computed tomography features of nontuberculous mycobacterial pulmonary disease versus asymptomatic colonization: A cross-sectional cohort study. J. Thorac. Imaging. 37(3), 140–145 (2022).
doi: 10.1097/RTI.0000000000000610 pubmed: 34292274
Eisenberg, I. et al. Radiologic characteristics of non-tuberculous mycobacteria infection in patients with bronchiectasis. Lung. 198(4), 715–722 (2020).
doi: 10.1007/s00408-020-00371-0 pubmed: 32591896
Shin, S. H. et al. Nontuberculous mycobacterial lung diseases caused by mixed infection with Mycobacterium avium complex and Mycobacterium abscessus complex. Antimicrob. Agents Chemother. 62(10), e01105-e1118. https://doi.org/10.1128/AAC.01105-18 (2018).
doi: 10.1128/AAC.01105-18 pubmed: 30104265 pmcid: 6153851
van Tonder, A. J. et al. Mycobacterium avium complex (MAC) genomics and transmission in a London hospital. Eur. Respir. J. 61, 2201237. https://doi.org/10.1183/13993003.01237-2022 (2022).
doi: 10.1183/13993003.01237-2022
Kwak, N., Lee, J. H., Kim, H. J., Kim, S. A. & Yim, J. J. New-onset nontuberculous mycobacterial pulmonary disease in bronchiectasis: Tracking the clinical and radiographic changes. BMC Pulm. Med. 20(1), 293 (2020).
doi: 10.1186/s12890-020-01331-3 pubmed: 33172424 pmcid: 7653824

Auteurs

Teodora Biciusca (T)

Department of Radiology, Goethe University, University Hospital Frankfurt, Frankfurt am Main, Germany.

Ann-Sophie Zielbauer (AS)

Department of Internal Medicine, Infectious Diseases, Goethe University, University Hospital Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany.

Thomas Anton (T)

Department of Internal Medicine, Infectious Diseases, Goethe University, University Hospital Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany.

Lisa Marschall (L)

Department of Internal Medicine, Infectious Diseases, Goethe University, University Hospital Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany.

Raja Idris (R)

Department of Internal Medicine, Infectious Diseases, Goethe University, University Hospital Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany.

Julia Koepsell (J)

Department of Internal Medicine, Infectious Diseases, Goethe University, University Hospital Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany.

Lisa J Juergens (LJ)

Department of Radiology, Goethe University, University Hospital Frankfurt, Frankfurt am Main, Germany.

Jennifer Gotta (J)

Department of Radiology, Goethe University, University Hospital Frankfurt, Frankfurt am Main, Germany.

Vitali Koch (V)

Department of Radiology, Goethe University, University Hospital Frankfurt, Frankfurt am Main, Germany.

Thomas A Wichelhaus (TA)

Institute of Medical Microbiology and Infection Control, Goethe University, University Hospital Frankfurt, Frankfurt am Main, Germany.

Thomas J Vogl (TJ)

Department of Radiology, Goethe University, University Hospital Frankfurt, Frankfurt am Main, Germany.

Maria J G T Vehreschild (MJGT)

Department of Internal Medicine, Infectious Diseases, Goethe University, University Hospital Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany.
Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Frankfurt am Main, Germany.

Simon S Martin (SS)

Department of Radiology, Goethe University, University Hospital Frankfurt, Frankfurt am Main, Germany.

Nils Wetzstein (N)

Department of Internal Medicine, Infectious Diseases, Goethe University, University Hospital Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany. wetzstein@med.uni-frankfurt.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH